Skip to content

Pathophysiologic Study to Understand and Possibly Treat Nocturia

Pathophysiologic Study to Understand and Possibly Treat Nocturia

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05298384
Enrollment
0
Registered
2022-03-28
Start date
2024-08-31
Completion date
2024-11-30
Last updated
2024-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nocturia

Brief summary

This study will mainly look at how well compression stockings decrease body weight between morning and night and the number of nocturia events, by preventing blood from pooling in your legs. Also, this research study is being done to collect the thoughts/reactions/opinions on how nocturia affects the life of one who suffers from nocturia.

Detailed description

This study intends to investigate the different causes nocturia. Patients with nocturia will be assigned to wearing knee high then thigh high compression stockings to assess the effect on weight gain during the day and the number of nocturia events. Renin and aldosterone levels will also be assessed. Furthermore, fluorescein dye will be used to to demonstrate vascular leakage of the fluorescent dye.

Interventions

Graduated compression stockings (GCS) are used to treat chronic venous diseases and edema. They help to improve blood flow and prevent blood pooling in the legs. The use of GCS will be in accordance with this indication. The greatest pressure is exerted at the ankle with gradually decreasing pressures up the length of the stockings. GCS are designed for use out of bed and are manufactured using strict medical and technical specifications.

Sponsors

NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 110 Years
Healthy volunteers
No

Inclusion criteria

* Age above or equal to 18 years at the time of signing informed consent * Willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures * Evidence of a personally signed and dated informed consent document indicating that the patient has been informed of all pertinent aspects of the study prior to initiation of any protocol-mandated procedures.

Exclusion criteria

* Suspected or proven peripheral arterial disease, including history of peripheral arterial bypass grafting * Any sensory impairment such as severe peripheral neuropathy as evidenced by patient reported intermittent claudication and/or signs of ischemia such as blue toes. * Allergy to stocking textile material. * Leg edema or pulmonary edema from congestive heart failure. * Local skin or soft-tissue condition, including recent skin graft, gangrene, oozing dermatitis and severe cellulitis. * Extreme deformity of the leg, or unusual leg shape or size that would prevent correct fit. * Treatment with any diuretics such as furosemide or hydrochlorothiazide.

Design outcomes

Primary

MeasureTime frameDescription
Change in the level of nocturiaBaseline, Day 11-20 visit, Day 21-30 visitTo measure the reduction of nocturia by the absolute change in body weight between morning and night and nocturia events at baseline and after compression stocking use.
Change in the quality of life for people with nocturiaBaseline visit, Day 20 visitTo measure the effect of nocturia on Quality of Life by the percent change in QOL score when comparing baseline and 20 days of treatment with compression stockings.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026